ORTEXORTEX News
Live short interest, options flow, and signals — free on ORTEX.Sign up free →
Market Commentary

Earnings Week Puts Options Traders on Edge

By ORTEX News · Edited by , Editor, ORTEX NewsUpdated 1 min read

Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish

ShareXLinkedInReddit

A busy earnings calendar is shaping options positioning heading into Monday. The clearest signal sits in CoreWeave, which carries 26.3% short interest of free float and an ORTEX short score of 68. The stock is down 39% year-to-date. Expiries cluster at the November 13 and November 20 dates, with traders targeting next week's print.

Rigetti Computing drew attention after a 19% single-session spike. Despite that move, shorts held firm at 21.4% of free float. Borrow availability sits at just 34.7%, meaning the squeeze fuel is there but lenders are scarce. The quantum computing name has near-term expiries lined up through January 2027.

Quantum peer D-Wave Quantum goes into earnings with shorts trapped and borrow exhausted. Its ORTEX short score reads 74, the highest of the group. Days to cover stand at 11.97, meaning any sharp move could force rapid covering.

Moderna is the large-cap name to watch. The stock is up 719% year-to-date. Availability is 439% of short interest, meaning plenty of borrow exists but shorts are still present at 8.9% of free float. ORTEX's Index Rebalance Radar gives Moderna an 88% probability of joining the MSCI World, with an estimated $6.4 billion of forced buying tied to that event. That flow, combined with earnings due next week, is drawing call activity toward the November 13 expiry.

Cisco completes a week packed with prints. Options chains out to January 2027 are open, suggesting traders are positioning beyond the immediate result.

Stocks in this article

How this article was generated

Generated
7 Nov 2026, 04:42
Prompt version
v1.0
Data sources
Options flowORTEX Alpha signalsAlt DataIndex Rebalance

ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.